首页 | 本学科首页   官方微博 | 高级检索  
     


Molecular Convergence of Neurodevelopmental Disorders
Authors:Elizabeth?S. Chen  Carolina?O. Gigek  Jill?A. Rosenfeld  Alpha?B. Diallo  Gilles Maussion  Gary?G. Chen  Kathryn Vaillancourt  Juan?P. Lopez  Liam Crapper  Rapha?l Poujol  Lisa?G. Shaffer  Guillaume Bourque  Carl Ernst
Affiliation:1.Department of Psychiatry, McGill University, Montreal, QC H4H 1R3, Canada;2.McGill Group for Suicide Studies, Douglas Hospital Research Institute, Montreal, QC H4H 1R3, Canada;3.Signature Genomic Laboratories, PerkinElmer Inc., Spokane, WA 99207, USA;4.Department of Human Genetics, McGill University, Montreal, QC H4H 1R3, Canada;5.Paw Print Genetics, Genetic Veterinary Sciences Inc., Spokane, WA 99202, USA;6.McGill University and Genome Quebec Innovation Center, Montreal, QC H3A 0G1, Canada
Abstract:Neurodevelopmental disorders (NDDs) are caused by mutations in diverse genes involved in different cellular functions, although there can be crosstalk, or convergence, between molecular pathways affected by different NDDs. To assess molecular convergence, we generated human neural progenitor cell models of 9q34 deletion syndrome, caused by haploinsufficiency of EHMT1, and 18q21 deletion syndrome, caused by haploinsufficiency of TCF4. Using next-generation RNA sequencing, methylation sequencing, chromatin immunoprecipitation sequencing, and whole-genome miRNA analysis, we identified several levels of convergence. We found mRNA and miRNA expression patterns that were more characteristic of differentiating cells than of proliferating cells, and we identified CpG clusters that had similar methylation states in both models of reduced gene dosage. There was significant overlap of gene targets of TCF4 and EHMT1, whereby 8.3% of TCF4 gene targets and 4.2% of EHMT1 gene targets were identical. These data suggest that 18q21 and 9q34 deletion syndromes show significant molecular convergence but distinct expression and methylation profiles. Common intersection points might highlight the most salient features of disease and provide avenues for similar treatments for NDDs caused by different genetic mutations.
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号